Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease

dc.authoridINANC, IBRAHIM HALIL/0000-0003-4046-6748
dc.authoridAkboga, Mehmet Kadri/0000-0001-5498-2837
dc.contributor.authorAkboga, Mehmet Kadri
dc.contributor.authorInanc, Ibrahim Halil
dc.date.accessioned2025-01-21T16:43:29Z
dc.date.available2025-01-21T16:43:29Z
dc.date.issued2022
dc.departmentKırıkkale Üniversitesi
dc.description.abstract[Abstract No tAvailable]
dc.identifier.doi10.1177/00033197211047326
dc.identifier.endpage282
dc.identifier.issn0003-3197
dc.identifier.issn1940-1574
dc.identifier.issue3
dc.identifier.pmid34634211
dc.identifier.startpage281
dc.identifier.urihttps://doi.org/10.1177/00033197211047326
dc.identifier.urihttps://hdl.handle.net/20.500.12587/25278
dc.identifier.volume73
dc.identifier.wosWOS:000708066000001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSage Publications Inc
dc.relation.ispartofAngiology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.titlePlasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease
dc.typeLetter

Dosyalar